693 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure http://www.zacks.com/stock/news/225378/biotech-stock-roundup-biogen-q2-results-impress-gilead-hcv-franchise-under-pressure?cid=CS-ZC-FT-225378 Jul 27, 2016 - With the second quarter earnings season in full swing, several biotech companies including Amgen (AMGN) will be reporting this week.
5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More http://www.zacks.com/stock/news/225060/5-drug-stocks-earnings-on-jul-27-amgn-vrtx-more?cid=CS-ZC-FT-225060 Jul 26, 2016 - How will drug stocks like AMGN, GSK, VRTX and others, scheduled to report on Jul 27, fare this earnings season?
AbbVie (ABBV) Q2 Earnings: Will the Stock Pull a Surprise? http://www.zacks.com/stock/news/225026/abbvie-abbv-q2-earnings-will-the-stock-pull-a-surprise?cid=CS-ZC-FT-225026 Jul 26, 2016 - Will Imbruvica and Humira help AbbVie (ABBV) deliver a positive earnings surprise in Q2?
Alexion (ALXN) Q2 Earnings: Stock Likely to Disappoint http://www.zacks.com/stock/news/225072/alexion-alxn-q2-earnings-stock-likely-to-disappoint?cid=CS-ZC-FT-225072 Jul 26, 2016 - Alexion Pharmaceuticals (ALXN), which is set to report second-quarter 2016 results on Jul 28, had delivered a negative earnings surprise of 4.40% last quarter.
Merck (MRK) Q2 Earnings: Will the Stock Pull a Surprise? http://www.zacks.com/stock/news/224920/merck-mrk-q2-earnings-will-the-stock-pull-a-surprise?cid=CS-ZC-FT-224920 Jul 26, 2016 - Merck (MRK) had posted a positive earnings surprise in Q1. Will the stock deliver a positive surprise again this quarter?
ARIAD (ARIA) to Report Q2 Earnings: Will the Stock Surprise? http://www.zacks.com/stock/news/224914/ariad-aria-to-report-q2-earnings-will-the-stock-surprise?cid=CS-ZC-FT-224914 Jul 26, 2016 - Focus will remain on the performance of ARIAD's (ARIA) leukemia drug, Iclusig.
Biotech Earnings Battle: Gilead (GILD) vs. Amgen (AMGN) http://www.zacks.com/stock/news/224867/biotech-earnings-battle-gilead-gild-vs-amgen-amgn?cid=CS-ZC-FT-224867 Jul 25, 2016 - Amgen and Gilead Sciences are both reporting earnings this week. Which company is the better bet right now?
Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2 http://www.zacks.com/stock/news/224851/bristol-myers-bmy-stock-to-beat-earnings-again-in-q2?cid=CS-ZC-FT-224851 Jul 25, 2016 - Bristol-Myers Squibb (BMY), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.12% last quarter.
Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise? http://www.zacks.com/stock/news/224843/celgene-celg-q2-earnings-can-the-stock-pull-a-surprise?cid=CS-ZC-FT-224843 Jul 25, 2016 - Celgene Corporation (CELG), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.38% last quarter.
Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen http://www.zacks.com/stock/news/224756/zacks-industry-outlook-highlights-bristol-myers-pfizer-sanofi-amgen-and-biogen?cid=CS-ZC-FT-224756 Jul 25, 2016 - Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen

Pages: 1...6061626364656667686970

<<<Page 65>